Literature DB >> 6108623

Prostacyclin therapy in peripheral arterial disease.

A Szczeklik, R J Gryglewski, R Nizankowski, S Skawiński, P Głuszko, R Korbut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6108623     DOI： 10.1016/0049-3848(80)90418-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Clinical studies on the vasodilating and anti-platelet effects of OP-41483, a prostacyclin derivative.

Authors:  A Kusaba; H Shiroma; D R Shrestha; K Koja; M Kina; Y Kuniyoshi; K Iha; O Kinjo; M Akasaki; T Kugai
Journal:  Jpn J Surg       Date:  1991-01

2.  No pharmacokinetic interaction between iloprost and digoxin.

Authors:  E Penin; G Cheymol; K Bouslama; A Benchouieb; J Cabane; G Souvignet
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.

Authors:  H Darius; V Hossmann; K Schrör
Journal:  Klin Wochenschr       Date:  1986-06-16

4.  The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors:  K Schrör; H Darius; R Matzky; R Ohlendorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

5.  Prostaglandin therapy in severe limb ischemia.

Authors:  B J Pardy; H H Eastcott
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

6.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 7.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

8.  Stability of prostacyclin analogues: an unusual lack of reactivity in acid-catalyzed alkene hydration.

Authors:  A Magill; C O'Yang; M F Powell
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

9.  Effect of prostacyclin on vascular capacity in the dog.

Authors:  T G Fulghum; J P DiMarco; E W Supple; I Nash; J Gendlerman; D F Eton; J B Newell; R M Zusman; W J Powell
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.

Authors:  V Hossmann; H Auel; W Rücker; K Schrör
Journal:  Klin Wochenschr       Date:  1984-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.